3/14
11:03 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
11:03 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
08:55 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
08:49 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
08:49 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
08:45 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
08:37 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
08:37 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
3/14
08:30 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
High
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
3/14
08:30 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
High
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
3/14
08:30 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $2.00 price target on the stock, down previously from $9.00.
High
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $2.00 price target on the stock, down previously from $9.00.
3/14
08:30 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $2.00 price target on the stock, down previously from $9.00.
High
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $2.00 price target on the stock, down previously from $9.00.
3/14
08:08 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
High
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
3/5
10:35 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $9.00 price target on the stock.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $9.00 price target on the stock.
3/5
10:35 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $9.00 price target on the stock.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $9.00 price target on the stock.
3/5
09:56 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
3/5
09:56 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
2/26
10:44 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
2/26
10:44 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
2/21
07:43 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
2/21
07:43 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
2/21
07:27 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) is now covered by analysts at Guggenheim. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) is now covered by analysts at Guggenheim. They set a "buy" rating and a $10.00 price target on the stock.
2/21
07:27 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) is now covered by analysts at Guggenheim. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) is now covered by analysts at Guggenheim. They set a "buy" rating and a $10.00 price target on the stock.
2/21
06:33 am
sprb
Spruce Biosciences initiated with bullish view at Guggenheim
Medium
Report
Spruce Biosciences initiated with bullish view at Guggenheim
2/21
06:33 am
sprb
Spruce Biosciences initiated with bullish view at Guggenheim
Medium
Report
Spruce Biosciences initiated with bullish view at Guggenheim